Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Only secondary source (analytical purity of TS not specified, limited documentation).

Data source

Referenceopen allclose all

Reference Type:
secondary source
Title:
Final Report on the Safety Assessment of Sorbitan Caprylate, Sorbitan Cocoate, Sorbitan Diisostearate, Sorbitan Dioleate, Sorbitan Distearate, Sorbitan Isostearate, Sorbitan Olivate, Sorbitan Sesquiisostearate, Sorbitan Sesquistearate, and Sorbitan Tri...
Author:
Lanigan RS, Yamarik TA; Cosmetic Ingredient Review Expert Panel
Year:
2002
Bibliographic source:
International Journal of Toxicology 21(suppl. 1): 93-112
Reference Type:
study report
Title:
Unnamed
Year:
1998
Report date:
1998

Materials and methods

Type of sensitisation studied:
skin
Study type:
study with volunteers
Principles of method if other than guideline:
RIPT
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Sorbitan, isooctadecanoate
EC Number:
276-171-2
EC Name:
Sorbitan, isooctadecanoate
Cas Number:
71902-01-7
Molecular formula:
C23H48O8
IUPAC Name:
2-(3,4-dihydroxyoxolan-2-yl)-2-hydroxyethyl 3-methylheptadecanoate
Details on test material:
- Name of test material (as cited in study report): sorbitan isostearate

Method

Type of population:
general
Subjects:
- Number of subjects exposed: 201
Route of administration:
dermal
Details on study design:
TYPE OF TEST(S) USED: patch test (epicutaneous test) applied on the upper arm or back

ADMINISTRATION
- Type of application: occlusive, induction period of 48 to 72 hours
- Concentrations: 2.5%
- Volume applied: 0.2 g
- Testing/scoring schedule: patches were applied 3 times per week for 3 weeks, after a 2-week non-treatment period, a 72-hour challenge patch was applied to a previously unexposed skin site.

EXAMINATIONS
Reactions were scored at 96 hours post appliation.

Results and discussion

Results of examinations:
NO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION
- Number of subjects with positive reactions: 0
- Number of subjects with negative reactions: 201
- Number of subjects with equivocal reactions: 0
- Number of subjects with irritating reactions: 0

Applicant's summary and conclusion

Conclusions:
The test substance did not induce a sensitisation response in humans under the test conditions chosen.